within Pharmacolibrary.Drugs.ATC.S;

model S01XA28
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.175,
    adminDuration  = 600,
    adminMass      = 0.001,
    adminCount     = 1,
    Vd             = 0.21,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor, used as a smoking cessation aid to reduce nicotine craving and withdrawal symptoms. It is approved for use in many countries and is generally administered orally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data for varenicline ophthalmic solution (S01XA28) is not available in published sources. Estimated parameters are derived based on extrapolation from oral varenicline, as there are currently no peer-reviewed studies reporting PK for the ocular route.</p><h4>References</h4><ol><li><p>Wu, X, et al., &amp; Wang, H (2022). Semi-PBPK Modeling and Simulation to Evaluate the Local and Systemic Pharmacokinetics of OC-01(Varenicline) Nasal Spray. <i>Frontiers in pharmacology</i> 13 910629–None. DOI:<a href=&quot;https://doi.org/10.3389/fphar.2022.910629&quot;>10.3389/fphar.2022.910629</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35873554/&quot;>https://pubmed.ncbi.nlm.nih.gov/35873554</a></p></li><li><p>Nau, J, et al., &amp; Crean, CS (2021). A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline. <i>Clinical therapeutics</i> 43(9) 1595–1607. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2021.07.020&quot;>10.1016/j.clinthera.2021.07.020</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34456060/&quot;>https://pubmed.ncbi.nlm.nih.gov/34456060</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01XA28;
